Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients

International Journal of Clinical Oncology

Volumn 15, Issue 3, 2010, Pages 263-270

  Komori, Hiroyuki ^a   Beppu, Toru ^a   Baba, Yoshifumi ^a   Horino, Kei ^a   Imsung, Choi ^a   Masuda, Toshiro ^a   Hayashi, Hiromitsu ^a   Okabe, Hirohisa ^a   Ootao, Ryuu ^a   Watanabe, Masayuki ^a   Takamori, Hiroshi ^a   Iyama, Kenichi ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Colorectal liver metastases; Fluorouracil and leucovorin (FOLFOX); Hepatic resection; Oxaliplatin; Postoperative morbidity; Sinusoidal dilatation

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FUNCTION; LIVER INJURY; LIVER METASTASIS; LIVER SINUSOID; MALE; MORBIDITY; MULTIPLE CYCLE TREATMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SURGICAL MORTALITY; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CHI SQUARE DISTRIBUTION; COLORECTAL TUMOR; CONVALESCENCE; DRUG EFFECTS; JAPAN; LESIONS AND DEFECTS; LIVER; LIVER FUNCTION TEST; LIVER NEOPLASMS; LIVER RESECTION; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; SECONDARY; TIME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DILATATION, PATHOLOGIC; FEMALE; FLUOROURACIL; HEPATECTOMY; HUMANS; JAPAN; LEUCOVORIN; LIVER; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; RECOVERY OF FUNCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955676742     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-010-0046-9     Document Type: Article

References (40)

1. Scheele J (1993) Hepatectomy for liver metastases. Br J Surg 80:274-276
2. Steele G Jr, Ravikumar TS (1989) Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210:127-138
3. Kato T, Yasui K, Hirai T et al (2003) Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 46:S22-S31
4. Martin LW, Warren RS (2000) Current management of colorectal liver metastases. Surg Oncol Clin N Am 9:853-876 (discussion 877-878)
5. Penna C, Nordlinger B (2002) Colorectal metastasis (liver and lung). Surg Clin North Am 82:1075-1090 (x-xi)
6. Rodgers MS, McCall JL (2000) Surgery for colorectal liver metastases with hepatic lymph node involvement: a systematic review. Br J Surg 87:1142-1155
7. Mathijssen RH, van Alphen RJ, Verweij J et al (2001) Clinical pharmacokinetics and metabolism of irinotecan (CPT-11). Clin Cancer Res 7:2182-2194
8. Carrato A, Gallego J, Diaz-Rubio E (2002) Oxaliplatin: results in colorectal carcinoma. Crit Rev Oncol Hematol 44:29-44
9. Colucci G, Gebbia V, Paoletti G et al (2005) Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell'Italia Meridionale. J Clin Oncol 23:4866-4875
10. de Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947
11. Jaeck D, Oussoultzoglou E, Rosso E et al (2004) two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240:1037-1049 (discussion 1049-1051)
12. Adam R, Delvart V, Pascal G et al (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240:644-657 (discussion 657-658)
13. Abdalla EK, Barnett CC, Doherty D et al (2002) Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 137:675-680 (discussion 680-681)
14. Peppercorn PD, Reznek RH, Wilson P et al (1998) Demonstration of hepatic steatosis by computerized tomography in patients receiving 5-fluorouracil-based therapy for advanced colorectal cancer. Br J Cancer 77:2008-2011
15. Zeiss J, Merrick HW, Savolaine ER et al (1990) Fatty liver change as a result of hepatic artery infusion chemotherapy. Am J Clin Oncol 13:156-160
16. Parikh AA, Gentner B, Wu TT et al (2003) Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7:1082-1088
17. Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-2072
18. Fernandez FG, Ritter J, Goodwin JW et al (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200:845-853
19. Zorzi D, Laurent A, Pawlik TM et al (2007) Chemotherapyassociated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94:274-286
20. Rubbia-Brandt L, Audard V, Sartoretti P et al (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15:460-466
21. Karoui M, Penna C, Amin-Hashem M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1-7 (Pubitemid 43054046)
22. Andre T, Bensmaine MA, Louvet C et al (1999) Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen. J Clin Oncol 17:3560-3568
23. Bilchick AJ, Poston G, Curley SA et al (2005) Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 23:9073-9078
24. Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313-1321
25. Aloia T, Sebagh M, Plasse M et al (2006) Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol 24:4983-4990
26. Pocard M, Vincent-Salomon A, Girodet J et al (2001) Effects of preoperative chemotherapy on liver function tests after hepatectomy. Hepatogastroenterology 48:1406-1408
27. Parc Y, Dugue L, Farges O et al (2000) Preoperative systemic 5- fluorouracil does not increase the risk of liver resection. Hepatogastroenterology 47:1703-1705
28. Rubbia-Brandt L, Mentha G, Terris B (2006) Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases. J Am Coll Surg 202:199-200
29. Reiss U, Cowan M, McMillan A et al (2002) Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. J Pediatr Hematol Oncol 24:746-750
30. Saltz LB, Clarke S, Diaz-Rubio E et al (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 26:2013-2019
31. Ribero D, Wang H, Donadon M et al (2007) Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastasis. Cancer 110:2761-2767
32. Kooby DA, Stockman J, Ben-Porat L et al (2003) Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg 237:860-869 (discussion 869-870)
33. Scheele J, Stang R, Altendorf-Hofmann A et al (1995) Resection of colorectal liver metastases. World J Surg 19:59-71
34. Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230:309-318 (discussion 318-321)
35. Fortner JG, Silva JS, Golbey RB et al (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199:306-316
36. Adson MA, van Heerden JA, Adson MH et al (1984) Resection of hepatic metastases from colorectal cancer. Arch Surg 119:647-651
37. Minagawa M, Makuuchi M, Torzilli G et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231:487-499
38. Nakano H, Oussoultzoglou E, Rosso E et al (2008) Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 247:118-124
39. Scoggins CR, Campbell ML, Landry CS et al (2009) Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastasis. Ann Surg Oncol 16:35-41
40. Tournigand C, Andre T, Achille E et al (2004) FOLFIRI followed by FOLFOX or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22:229-237